Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JMS Co's EPS (Basic) for the
six
months ended in Mar. 2026 was 円-24.17.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was 円-31.95.
JMS Co's EPS without NRI for the
six
months ended in Mar. 2026 was 円-6.76.
Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was 円-14.13.
During the past 12 months, JMS Co's average EPS without NRIGrowth Rate was -766.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, JMS Co's highest 3-Year average EPS without NRI Growth Rate was 152.90% per year. The lowest was -60.80% per year. And the median was -8.40% per year.
JMS Co (TSE:7702) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
JMS Co EPS (Diluted) Related Terms
JMS Co EPS (Diluted) Historical Data
* Premium members only.
The historical data trend for JMS Co's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7702 vs ISRG, BDX, MDLN: EPS (Diluted) Comparison
For the Medical Instruments & Supplies subindustry, JMS Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMS Co PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMS Co's PE Ratio distribution charts can be found below:
* The bar in red indicates where JMS Co's PE Ratio falls into.
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
JMS Co's Diluted EPS for the fiscal year that ended in Mar. 2026 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-31.95
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMS Co (TSE:7702) has a EPS (Diluted) of 円-31.95 as of Mar. 2026. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on JMS Co and its competitors.
Is JMS Co's EPS (Diluted) too high?
JMS Co's current EPS (Diluted) is 円-31.95. Overall, JMS Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JMS Co's EPS (Diluted) compare to ISRG and BDX?
JMS Co's EPS (Diluted) of 円-31.95 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Medical Devices & Instruments company?
A good EPS (Diluted) depends on the Medical Devices & Instruments industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on JMS Co and its competitors. JMS Co's current EPS (Diluted) is 円-31.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMS Co stock overvalued right now?
Based on GuruFocus' analysis, JMS Co (TSE:7702) is currently considered Fairly Valued. The stock's GF Value™ is 円469.13, compared to a current price of 円459.00 — trading 2.2% below its estimated fair value. The current EPS (Diluted) is 円-31.95. JMS Co's overall GF Score™ is 62/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For JMS Co (TSE:7702), the current EPS (Diluted) is 円-31.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMS Co (TSE:7702) Overvalued in 2026?
Based on GuruFocus' analysis, JMS Co stock appears to be undervalued.
The current stock price of 円459.00 is trading 2.2% below its estimated GF Value™ of 円469.13.
GuruFocus considers JMS Co to be Fairly Valued.
Key valuation signals for TSE:7702:
EPS (Diluted): 円-31.95
GF Value™: 円469.13 vs. price of 円459.00 (2.2% below fair value)
No single metric tells the full story. See the TSE:7702 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMS Co Ltd is a Japan-based medical equipment manufacturer. The company is engaged in the manufacture, sale, export, and import of medical equipment and pharmaceuticals. Products offered by the company include an infusion pump, syringe pump, surgical gown, peritoneal dialysate, dialyzer, mask cap, sheet for treatment, pacemaker, heat exchanger, blood bag, among others. JMS has network operations in various countries including Europe, North America, Asia, the Middle East, Latin America and Africa.
62GF Score
Get the complete analysis for TSE:7702
EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7702 has been successfully added to your 
